• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

破裂脑动脉瘤患者预防性再出血方案的结果:一项回顾性队列研究

Results of a Preventive Rebleeding Protocol in Patients with Ruptured Cerebral Aneurysm: A Retrospective Cohort Study.

作者信息

Duangthongphon Pichayen, Souwong Bunika, Munkong Waranon, Kitkhuandee Amnat

机构信息

Department of Surgery, The Center of Excellence of Neurovascular Intervention and Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

Department of Radiology, The Center of Excellence of Neurovascular Intervention and Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

出版信息

Asian J Neurosurg. 2019 Jul-Sep;14(3):748-753. doi: 10.4103/ajns.AJNS_32_19.

DOI:10.4103/ajns.AJNS_32_19
PMID:31497096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6703019/
Abstract

OBJECTIVE

In 2015, a protocol to prevent rebleeding was implemented to improve the outcome of patients with ruptured intracranial aneurysm. We performed a single-center retrospective analysis to compare the outcomes of pre/post using protocol.

METHODOLOGY

Over a 3-year period, 208 patients with ruptured cerebral aneurysm were treated at our institution. The protocol for preventing rebleeding was initiated in 2015. We compared the two cohorts between the group of patients before initiating the protocol ( = 104) and after initiating the protocol ( = 104). We analyzed the protocol for preventing rebleeding which consisted of absolute bed rest, adequate pain control, avoiding stimuli (R), keeping euvolemia (E), preoperative systolic blood pressure <160 mmHg and within 140-180 mmHg after definite treatment (S), a short course (<72 h) of intravenous transaminic acid, and aneurysm treatment as early as possible (T). Outcomes are presented as in-hospital rebleeding, delayed cerebral ischemia (DCI), and proportion of unfavorable outcomes (score of 4-6 on a modified Rankin scale at 6 and 12 months).

RESULTS

Postprotocol, there was a reduction in the incidence of in-hospital rebleeding from 6.7% to 2.8% ( = 0.20, odds ratio [OR] = 0.4, 95% confidence interval [CI] = 0.10-1.63) and in the proportion of patients who presented with good WFNS grades (1-3) with unfavorable clinical outcomes at 12 months from 27.0% to 12.8% ( = 0.03, OR = 0.40, 95% CI = 0.17-0.95). The DCI experienced a significant reduction from 44.2% to 7.7% ( < 0.001, OR = 0.10, 95% CI = 0.04-0.23), and their 180-day mortality rate in good WFNS grades patients decreased from 16.3% to 8.8% (hazard ratio 0.80, 95% CI = 0.28-2.28).

CONCLUSION

Ruptured cerebral aneurysm patients benefit from this protocol due to its ability to reduce the incidence of DCI and reduce unfavorable outcome on good WFNS grade patients.

摘要

目的

2015年实施了一项预防再出血的方案,以改善颅内动脉瘤破裂患者的治疗效果。我们进行了一项单中心回顾性分析,以比较使用该方案前后的治疗效果。

方法

在3年期间,我们机构共治疗了208例脑动脉瘤破裂患者。预防再出血的方案于2015年开始实施。我们比较了方案实施前(n = 104)和实施后(n = 104)两组患者。我们分析了预防再出血的方案,该方案包括绝对卧床休息、充分的疼痛控制、避免刺激(R)、维持血容量正常(E)、术前收缩压<160 mmHg以及明确治疗后收缩压维持在140 - 180 mmHg(S)、短期(<72小时)静脉输注氨基转氨酶,以及尽早进行动脉瘤治疗(T)。结果以院内再出血、迟发性脑缺血(DCI)以及不良结局的比例(改良Rankin量表在6个月和12个月时评分为4 - 6分)来呈现。

结果

方案实施后,院内再出血发生率从6.7%降至2.8%(P = 0.20,优势比[OR] = 0.4,95%置信区间[CI] = 0.10 - 1.63),12个月时WFNS分级良好(1 - 3级)但临床结局不良的患者比例从27.0%降至12.8%(P = 0.03,OR = 0.40,95% CI = 0.17 - 0.95)。DCI显著减少,从44.2%降至7.7%(P < 0.001,OR = 0.10,95% CI = 0.04 - 0.23),WFNS分级良好的患者180天死亡率从16.3%降至8.8%(风险比0.80,95% CI = 0.28 - 2.28)。

结论

脑动脉瘤破裂患者受益于该方案,因为它能够降低DCI的发生率,并减少WFNS分级良好患者的不良结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba4/6703019/fc594bd9602f/AJNS-14-748-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba4/6703019/fc594bd9602f/AJNS-14-748-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba4/6703019/fc594bd9602f/AJNS-14-748-g001.jpg

相似文献

1
Results of a Preventive Rebleeding Protocol in Patients with Ruptured Cerebral Aneurysm: A Retrospective Cohort Study.破裂脑动脉瘤患者预防性再出血方案的结果:一项回顾性队列研究
Asian J Neurosurg. 2019 Jul-Sep;14(3):748-753. doi: 10.4103/ajns.AJNS_32_19.
2
Formal protocol for emergency treatment of ruptured intracranial aneurysms to reduce in-hospital rebleeding and improve clinical outcomes.降低颅内动脉瘤破裂患者院内再出血率并改善临床结局的急诊治疗正式方案。
J Neurosurg. 2015 Feb;122(2):383-91. doi: 10.3171/2014.9.JNS131784. Epub 2014 Nov 18.
3
Aneurysm rebleeding after poor-grade aneurysmal subarachnoid hemorrhage: Predictors and impact on clinical outcomes.低级别动脉瘤性蛛网膜下腔出血后的动脉瘤再出血:预测因素及其对临床结局的影响。
J Neurol Sci. 2016 Dec 15;371:62-66. doi: 10.1016/j.jns.2016.10.020. Epub 2016 Oct 14.
4
Complications and outcomes after early surgical treatment for poor-grade ruptured intracranial aneurysms: A multicenter retrospective cohort.早期手术治疗低分级破裂颅内动脉瘤的并发症和转归:一项多中心回顾性队列研究。
Int J Surg. 2015 Nov;23(Pt A):57-61. doi: 10.1016/j.ijsu.2015.09.008. Epub 2015 Sep 10.
5
Coil embolization for intracranial aneurysms: an evidence-based analysis.颅内动脉瘤的弹簧圈栓塞术:一项基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(1):1-114. Epub 2006 Jan 1.
6
Clinical characteristics and factors relating to poor outcome in patients with aneurysmal subarachnoid hemorrhage in Vietnam: A multicenter prospective cohort study.越南颅内动脉瘤性蛛网膜下腔出血患者预后不良的临床特征及相关因素:一项多中心前瞻性队列研究。
PLoS One. 2021 Aug 13;16(8):e0256150. doi: 10.1371/journal.pone.0256150. eCollection 2021.
7
Ultra-early endovascular embolization of ruptured cerebral aneurysm and the increased risk of hematoma growth unrelated to aneurysmal rebleeding.超早期破裂脑动脉瘤血管内栓塞治疗与血肿增大风险增加无关,与动脉瘤再出血无关。
J Neurosurg. 2013 May;118(5):1003-8. doi: 10.3171/2012.11.JNS12610. Epub 2012 Dec 14.
8
Rebleeding After Aneurysmal Subarachnoid Hemorrhage in Two Centers Using Different Blood Pressure Management Strategies.在两个采用不同血压管理策略的中心,动脉瘤性蛛网膜下腔出血后的再出血情况
Front Neurol. 2022 Feb 21;13:836268. doi: 10.3389/fneur.2022.836268. eCollection 2022.
9
The Factors Associated with Outcomes in Surgically Managed Ruptured Cerebral Aneurysm.手术治疗破裂脑动脉瘤预后的相关因素
Malays J Med Sci. 2018 Feb;25(1):32-41. doi: 10.21315/mjms2018.25.1.5. Epub 2018 Feb 28.
10
Outcome after In-Hospital Rebleeding of Rupture of Intracranial Aneurysms.颅内动脉瘤破裂后院内再出血的结局
J Neurol Surg A Cent Eur Neurosurg. 2016 May;77(3):207-21. doi: 10.1055/s-0035-1570007. Epub 2016 Jan 25.

引用本文的文献

1
Long-term outcomes following the clipping of ruptured intracranial aneurysms of the anterior circulation: A retrospective institutional study.前循环破裂颅内动脉瘤夹闭术后的长期预后:一项机构回顾性研究。
Med Int (Lond). 2025 Jul 31;5(5):58. doi: 10.3892/mi.2025.257. eCollection 2025 Sep-Oct.
2
Outcomes following surgical clipping of re-ruptured previously untreated intracranial aneurysms.再次破裂的未经治疗的颅内动脉瘤手术后的结果。
Neurosurg Rev. 2024 Aug 20;47(1):442. doi: 10.1007/s10143-024-02657-w.
3
CT perfusion-guided administration of IV milrinone is associated with a reduction in delayed cerebral infarction after subarachnoid hemorrhage.

本文引用的文献

1
Timing of surgery for aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.颅内动脉瘤性蛛网膜下腔出血手术时机:系统评价和荟萃分析。
Int J Surg. 2017 Dec;48:266-274. doi: 10.1016/j.ijsu.2017.11.033. Epub 2017 Nov 28.
2
Formal protocol for emergency treatment of ruptured intracranial aneurysms to reduce in-hospital rebleeding and improve clinical outcomes.降低颅内动脉瘤破裂患者院内再出血率并改善临床结局的急诊治疗正式方案。
J Neurosurg. 2015 Feb;122(2):383-91. doi: 10.3171/2014.9.JNS131784. Epub 2014 Nov 18.
3
European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage.
CT 灌注引导下静脉注射米力农与蛛网膜下腔出血后迟发性脑梗死的减少有关。
Sci Rep. 2024 Jun 27;14(1):14856. doi: 10.1038/s41598-024-65706-w.
4
Emergency Medical Management of Aneurysmal Subarachnoid Hemorrhage.颅内动脉瘤性蛛网膜下腔出血的急诊处理。
Neurocrit Care. 2023 Aug;39(1):51-58. doi: 10.1007/s12028-023-01757-7. Epub 2023 Jun 21.
5
Guidelines for the Neurocritical Care Management of Aneurysmal Subarachnoid Hemorrhage.《动脉瘤性蛛网膜下腔出血神经重症监护管理指南》。
Neurocrit Care. 2023 Aug;39(1):1-28. doi: 10.1007/s12028-023-01713-5. Epub 2023 May 18.
6
Preoperative predictors of poor outcomes in Thai patients with aneurysmal subarachnoid hemorrhage.泰国颅内动脉瘤性蛛网膜下腔出血患者预后不良的术前预测因素。
PLoS One. 2022 Mar 15;17(3):e0264844. doi: 10.1371/journal.pone.0264844. eCollection 2022.
7
Rebleeding After Aneurysmal Subarachnoid Hemorrhage in Two Centers Using Different Blood Pressure Management Strategies.在两个采用不同血压管理策略的中心,动脉瘤性蛛网膜下腔出血后的再出血情况
Front Neurol. 2022 Feb 21;13:836268. doi: 10.3389/fneur.2022.836268. eCollection 2022.
欧洲卒中组织颅内动脉瘤和蛛网膜下腔出血管理指南。
Cerebrovasc Dis. 2013;35(2):93-112. doi: 10.1159/000346087. Epub 2013 Feb 7.
4
Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm.蛛网膜下腔出血后的迟发性脑缺血:超越血管痉挛的思考。
Br J Anaesth. 2012 Sep;109(3):315-29. doi: 10.1093/bja/aes264.
5
Rebleeding after aneurysmal subarachnoid hemorrhage: a literature review.颅内动脉瘤性蛛网膜下腔出血后再出血:文献综述。
World Neurosurg. 2013 Feb;79(2):307-12. doi: 10.1016/j.wneu.2012.06.023. Epub 2012 Jun 19.
6
Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association.颅内动脉瘤性蛛网膜下腔出血管理指南:美国心脏协会/美国卒中协会医疗保健专业人员指南。
Stroke. 2012 Jun;43(6):1711-37. doi: 10.1161/STR.0b013e3182587839. Epub 2012 May 3.
7
Treatment of ruptured aneurysms: earlier is better.破裂动脉瘤的治疗:越早越好。
World Neurosurg. 2012 Feb;77(2):263-5. doi: 10.1016/j.wneu.2011.12.073. Epub 2011 Dec 17.
8
Effect of rebleeding on the course and incidence of vasospasm after subarachnoid hemorrhage.再出血对蛛网膜下腔出血后血管痉挛的病程和发生率的影响。
Neurology. 2012 Jan 3;78(1):31-7. doi: 10.1212/WNL.0b013e31823ed0a4. Epub 2011 Dec 14.
9
Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference.动脉瘤性蛛网膜下腔出血患者的重症监护管理:来自神经重症监护学会多学科共识会议的建议。
Neurocrit Care. 2011 Sep;15(2):211-40. doi: 10.1007/s12028-011-9605-9.
10
Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects.蛛网膜下腔出血后引起的脑梗死通过血管痉挛依赖性和非依赖性作用导致不良预后。
Stroke. 2011 Apr;42(4):924-9. doi: 10.1161/STROKEAHA.110.597914. Epub 2011 Feb 10.